FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: Comparison with spiral CT

Annals of Oncology

Volumn 12, Issue 4, 2001, Pages 479-486

  Franzius, C ^a,b   Daldrup Link, H E ^a   Sciuk, J ^a   Rummeny, E J ^a   Bielack, S ^a   Jurgens H ^a   Schober, O ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Ewing's sarcoma; FDG PET; Malignant primary bone tumors; Osteosarcoma; Pulmonary metastases; Thoracic CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; ARTICLE; BONE TUMOR; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EWING SARCOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; PLEURA METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

ADOLESCENT; ADULT; BONE AND BONES; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; OSTEOSARCOMA; RADIOGRAPHY, THORACIC; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SARCOMA, EWING'S; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035019053     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011111322376     Document Type: Article

References (26)

1. Huvos AG. Bone Tumors, Diagnosis, Treatment and Prognosis. Montreal. Sydney, Tokyo: W.B. Saunders 1991.
2. Winkler K, Beron G, Delling G et al. Neoadjuvant chemotherapy of osteosarcoma: Results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 1988; 6: 329-37.
3. Jürgens H, Exner U, Gadner H et al. Multidisciplinary treatment of primary Ewing's sarcoma of bone in children and young adults: Six months of intensive combined modality therapy without maintenance. J Clin Oncol 1988; 88: 484-90.
4. Paulussen M, Ahrens S, Burdach S et al. Primary metastatic (stage IV) Ewing tumor: Survival analysis of 171 patients from EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies. Ann Oncol 1998; 9: 275-81.
5. Bruland OS, Pihl A. On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy. Eur J Cancer 1997; 33: 1725-31.
6. Meyers PA, Heller G, Healey JH et al. Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol 1993: 11: 449-53.
7. Lowe VJ, Fletcher JW, Gobar L et al. Prospective Investigation of Positron Emission Tomography in Lung Nodules. J Clin Oncol 1998; 16: 1075-84.
8. Kole AC, Nieweg OE, Hoekstra HJ et al. Fluorine-18-fluorodeoxyglucose assessment of glucose metabolism in bone tumors. J Nucl Med 1998; 39: 810-5.
9. Franzius C, Sciuk J, Brinkschmidt C et al. Evaluation of chemotherapy response in primary bone tumors with F-18-FDG-PET in comparison with histologically assessed tumor necrosis. Clin Nucl Med 2000; 25: 874-81.
10. Schulte M, Brecht-Krauss D, Werner M et al. Evaluation of neo-adjuvant therapy response of osteogenic sarcoma using FDG-PET. J Nucl Med 1999; 40: 1637-43.
11. Franzius C, Sciuk J, Daldrup-Link HE et al. FDG-PET for detection of osseous metastases from malignant primary bone tumors: Comparison with bone scintigraphy. Eur J Nucl Med 2000; 27: 1305-11.
12. Lowe VL, Hoffman JM, DeLong DM et al. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 1994; 35: 1771-6.
13. Tabone MD, Kalifa C, Rodary C et al. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy. J Clin Oncol 1994; 12: 2614-20.
14. Marina NM, Pratt CB, Rao BN et al. Improved prognosis of children with osteosarcoma metastatic to the lung(s) at the time of diagnosis. Cancer 1992; 70: 2722-7.
15. Vanel D, Henry-Amar M, Lumbroso J et al. Pulmonary evaluation of patients with osteosarcoma: Role of standard radiography, tomography, CT, scintigraphy, and tomoscintigraphy. Am J Roentgenol 1984; 143: 519-23.
16. Waters DJ, Coakley FV, Cohen MD et al. The detection of pulmonary metastases by Helical CT: A clinicopathologic study in dogs. J Comput Assist Tomogr 1998; 22: 235-40.
17. Lucas JD, O'Doherty MJ, Wong JCH et al. Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcoma. J Bone Joint Surg (Br) 1998; 80-B: 441-7.
18. Hoffman EJ, Huang S-C, Phelps ME. Quantitation in positron emission computed tomography: 1. Effect of object size. J Comp Assist Tomogr 1979; 3: 229-308.
19. Gupta NC, Maloof J, Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med 1996; 37: 943-8.
20. Präuer HW, Weber WA, Römer W et al. Evaluation of pulmonary nodules by positron emission tomography using the glucose analogue fluorine-18-fluorodeoxyglucose (FDG). a controlled prospective study in 50 patients. Br J Surg 1998; 85: 1506-11.
21. Brady AP, Ennis JT. The scintigraphic detection of ossifie media-stinal and pulmonary metastases in osteosarcoma. Br J Radiol 1990; 63: 978-80.
22. Pevarski DJ, Drane WE, Scarborough MT. The usefulness of bone scintigraphy with SPECT images for detection of pulmonary metastases from osteosarcoma. Am J Roentgenol 1998; 170: 319-22.
23. Kurata T, Oguri T, Isobe T et al. Differential expression of facilitative glucose transporter (GLUT) genes in primary lung cancers and their liver metastases. Jpn J Cancer Res 1999; 90: 1238-43.
24. Bengel FM, Ziegler SI, Avril N et al. Whole-body positron emission tomography in clinical oncology: Comparison between attenuation-corrected and uncorrected images. Eur J Nucl Med 1997; 24: 1091-8.
25. Bedigian MP, Benard F, Smith RJ et al. Whole-body positron emission tomography for oncology imaging using singles transmission scanning with segmentation and ordered subsets-expectation maximization (OS-EM) reconstruction. Eur J Nucl Med 1998; 25: 659-61.
26. Kotzerke J, Guhlmann A, Moog F et al. Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma. Eur J Nucl Med 1999; 26: 31-8.